Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04705038 · ClinicalTrials.gov registry record · NA

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

A NA study of Prostate Cancer, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04705038 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 100 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04705038, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).

Conditions Studied

Interventions

  • BEHAVIORAL Patient Education

Study Locations (1)

Illinois

  • University of Chicago Medicine Comprehensive Cancer Center - Chicago

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-12-18
Est. Completion 2027-12
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT04705038

The ClinicalTrials.gov registry entry for NCT04705038 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient Education is the first listed.

NCT04705038 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04705038 about?

NCT04705038 is a clinical study titled "Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments". The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).

What is the current status of trial NCT04705038?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-12-18. Estimated completion is 2027-12.

What conditions does trial NCT04705038 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04705038?

The interventions under investigation include: Patient Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04705038?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04705038 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.